Diagnosis of Zika virus infection by peptide array and enzyme-linked immunosorbent assay

mBio

Volumn 9, Issue 2, 2018, Pages

  Mishra, Nischay ^a   Caciula, Adrian ^a   Price, Adam ^a   Thakkar, Riddhi ^a   Ng, James ^a   Chauhan, Lokendra V ^a   Jain, Komal ^a   Che, Xiaoyu ^a   Espinosa, Diego A ^b   Cruz, Magelda Montoya ^b   Balmaseda, Angel ^c   Sullivan, Eric H ^d   Patel, Jigar J ^d   Jarman, Richard G ^e   Rakeman, Jennifer L ^f   Egan, Christina T ^g   Reusken, Chantal B E M ^h   Koopmans, Marion P G ^h   Harris, Eva ^b   Tokarz, Rafal ^a   Briese, Thomas ^a   Lipkin, W Ian ^a   more..

^a Department of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Ministry of Health   (Nicaragua)

^d Roche Madison   (United States)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^g WADSWORTH CENTER   (United States)

^h ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arbovirus; Emerging infectious diseases; Flavivirus; Serology; Zika

Indexed keywords

PROTEOME; VIRAL PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CHILD; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; ILHEUS VIRUS; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; NICARAGUA; NONHUMAN; OROPOUCHE VIRUS; PRIORITY JOURNAL; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY; SEROLOGY; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS VIRUS; VACCINATION; WEST NILE FEVER; WEST NILE VIRUS; YELLOW FEVER; YELLOW FEVER VIRUS; ZIKA FEVER; ARBOVIRUS; COMMUNICABLE DISEASE; FLAVIVIRUS; GENETICS; PATHOGENICITY; PROCEDURES; VIROLOGY; ZIKA VIRUS;

ARBOVIRUSES; COMMUNICABLE DISEASES, EMERGING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS; RNA, VIRAL; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85044457839     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00095-18     Document Type: Article

References (42)

1. World Health Organization. 2016. Laboratory testing for Zika virus infection: interim guidance. WHO/ZIKV/LAB/16.1. World Health Organization, Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/ 204671/1/WHO_ZIKV_LAB_16.1_eng.pdf.
2. Gulland A. 2016. Zika virus is a global public health emergency, declares WHO. BMJ 352:i657. https://doi.org/10.1136/bmj.i657.
3. Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. 2016. Zika virus and birth defects-reviewing the evidence for causality. N Engl J Med 374:1981-1987. https://doi.org/10.1056/NEJMsr1604338.
4. de Vasconcelos ZFM, Azevedo RC, Thompson N, Gomes L, Guida L, Moreira MEL. 2018. Challenges for molecular and serological ZIKV infection confirmation. Childs Nerv Syst 34:79-84. https://doi.org/10.1007/ s00381-017-3641-5.
5. Broutet N, Krauer F, Riesen M, Khalakdina A, Almiron M, Aldighieri S, Espinal M, Low N, Dye C. 2016. Zika virus as a cause of neurologic disorders. N Engl J Med 374:1506-1509. https://doi.org/10.1056/ NEJMp1602708.
6. Krauer F, Riesen M, Reveiz L, Oladapo OT, Martínez-Vega R, Porgo TV, Haefliger A, Broutet NJ, Low N, WHO Zika Causality Working Group. 2017. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: systematic review. PLoS Med 14:e1002203. https://doi.org/10.1371/journal.pmed.1002203.
7. Winkler CW, Woods TA, Rosenke R, Scott DP, Best SM, Peterson KE. 2017. Sexual and vertical transmission of Zika virus in anti-interferon receptortreated Rag1-deficient mice. Sci Rep 7:7176. https://doi.org/10.1038/ s41598-017-07099-7.
8. Davidson A, Slavinski S, Komoto K, Rakeman J, Weiss D. 2016. Suspected female-to-male sexual transmission of Zika virus-New York City, 2016. MMWR Morb Mortal Wkly Rep 65:716-717. https://doi.org/10.15585/ mmwr.mm6528e2.
9. Motta IJ, Spencer BR, Cordeiro da Silva SG, Arruda MB, Dobbin JA, Gonzaga YB, Arcuri IP, Tavares RC, Atta EH, Fernandes RF, Costa DA, Ribeiro LJ, Limonte F, Higa LM, Voloch CM, Brindeiro RM, Tanuri A, Ferreira OC, Jr. 2016. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med 375:1101-1103. https://doi.org/10.1056/ NEJMc1607262.
10. US Food and Drug Administration. 11 August 2017. CII-ArboViroPlex rRT-PCR assay: authorization of the emergency use of in vitro diagnostics for detection of Zika virus and/or diagnosis of Zika virus infection. US Food and Drug Administration, Washington, DC. https:// www.fda.gov/downloads/MedicalDevices/Safety/Emergency Situations/UCM571320.pdf.
11. Mansuy JM, Mengelle C, Pasquier C, Chapuy-Regaud S, Delobel P, Martin-Blondel G, Izopet J. 2017. Zika virus infection and prolonged viremia in whole-blood specimens. Emerg Infect Dis 23:863-865. https:// doi.org/10.3201/eid2305.161631.
12. Brasil P, Pereira JP, Jr, Moreira ME, Ribeiro Nogueira RM, Damasceno L, Wakimoto M, Rabello RS, Valderramos SG, Halai UA, Salles TS, Zin AA, Horovitz D, Daltro P, Boechat M, Raja Gabaglia C, Carvalho de Sequeira P, Pilotto JH, Medialdea-Carrera R, Cotrim da Cunha D, Abreu de Carvalho LM, Pone M, Machado Siqueira A, Calvet GA, Rodrigues Baião AE, Neves ES, Nassar de Carvalho PR, Hasue RH, Marschik PB, Einspieler C, Janzen C, Cherry JD, Bispo de Filippis AM, Nielsen-Saines K. 2016. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 375:2321-2334. https://doi.org/10.1056/NEJMoa1602412.
13. Buus S, Rockberg J, Forsström B, Nilsson P, Uhlen M, Schafer-Nielsen C. 2012. High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays. Mol Cell Proteomics 11:1790-1800. https://doi.org/10.1074/mcp.M112.020800.
14. Gonzalez JP, Souris M, Valdivia-Granda W. 2018. Global spread of hem-orrhagic fever viruses: predicting pandemics. Methods Mol Biol 1604:3-31. https://doi.org/10.1007/978-1-4939-6981-4_1.
15. Travassos da Rosa JF, de Souza WM, Pinheiro FP, Figueiredo ML, Cardoso JF, Acrani GO, Nunes MRT. 2017. Oropouche virus: clinical, epidemiological, and molecular aspects of a neglected Orthobunyavirus. Am J Trop Med Hyg 96:1019-1030. https://doi.org/10.4269/ajtmh.16-0672.
16. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193. https://doi.org/ 10.1093/bioinformatics/19.2.185.
17. Valentini D, Rao M, Rane L, Rahman S, Axelsson-Robertson R, Heuchel R, Löhr M, Hoft D, Brighenti S, Zumla A, Maeurer M. 2017. Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guerin vaccination. Int J Infect Dis 56:140-154. https://doi.org/10.1016/j.ijid.2017.01.027.
18. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. 2015. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47. https://doi.org/10.1093/ nar/gkv007.
19. Oshlack A, Emslie D, Corcoran LM, Smyth GK. 2007. Normalization of boutique two-color microarrays with a high proportion of differentially expressed probes. Genome Biol 8:R2. https://doi.org/10.1186/gb-2007-8-1-r2.
20. Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth GK. 2016. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat 10:946-963. https://doi.org/10.1214/16-AOAS920.
21. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 57:289-300.
22. Breiman L. 2001. Random forests. Mach Learn 45:5-32. https://doi.org/ 10.1023/A:1010933404324.
23. Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D. 2017. Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci U S A 114:8384-8389. https://doi.org/10.1073/pnas.1704984114.
24. El Nuevo Diario. 27 January 2016. Confirman dos casos positivos de Zika en Nicaragua. El Nuevo Diario, Managua, Nicaragua. https://www.elnuevodiario.com.ni/nacionales/383401-nicaragua-confirma-dos-casos-positivos-zika/.
25. L’Huillier AG, Hamid-Allie A, Kristjanson E, Papageorgiou L, Hung S, Wong CF, Stein DR, Olsha R, Goneau LW, Dimitrova K, Drebot M, Safronetz D, Gubbay JB. 2017. Evaluation of Euroimmun anti-Zika virus IgM and IgG enzyme-linked immunosorbent assays for Zika virus serologic testing. J Clin Microbiol 55:2462-2471. https://doi.org/10.1128/JCM.00442-17.
26. United Nations Development Programme. 6 April 2017. Social and economic costs of Zika can reach up to US$18 billion in Latin America and the Caribbean. United Nations Development Programme, New York, NY. http:// www.undp.org/content/undp/en/home/presscenter/pressreleases/2017/04/06/social-and-economic-costs-of-zika-can-reach-up-to-us-18-billion-in-latin-america-and-the-caribbean.html.
27. Melo AS, Aguiar RS, Amorim MM, Arruda MB, Melo FO, Ribeiro ST, Batista AG, Ferreira T, Dos Santos MP, Sampaio VV, Moura SR, Rabello LP, Gonzaga CE, Malinger G, Ximenes R, de Oliveira-Szejnfeld PS, Tovar-Moll F, Chimelli L, Silveira PP, Delvechio R, Higa L, Campanati L, Nogueira RM, Filippis AM, Szejnfeld J, Voloch CM, Ferreira OC, Jr, Brindeiro RM, Tanuri A. 2016. Congenital Zika virus infection: beyond neonatal microcephaly. JAMA Neurol 73:1407-1416. https://doi.org/10.1001/jamaneurol.2016.3720.
28. Lipkin WI. 6 September 2016. The coming trials of generation Zika: we may see an increase in the incidence of mental illness, Parkinson’s and dementia. The Wall Street Journal, New York, NY. https://www.wsj.com/ articles/the-coming-trials-of-generation-zika-1473203849.
29. Chang HH, Huber RG, Bond PJ, Grad YH, Camerini D, Maurer-Stroh S, Lipsitch M. 2017. Systematic analysis of protein identity between Zika virus and other arthropod-borne viruses. Bull World Health Organ 95:517-525I. https://doi.org/10.2471/BLT.16.182105.
30. Haug CJ, Kieny MP, Murgue B. 2016. The Zika challenge. N Engl J Med 374:1801-1803. https://doi.org/10.1056/NEJMp1603734.
31. Haddow AD, Woodall JP. 2016. Distinguishing between Zika and Spondweni viruses. Bull World Health Organ 94:711-711A. https://doi.org/10.2471/BLT.16.181503.
32. Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J. 2016. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A 113:7852-7857. https://doi.org/10.1073/ pnas.1607931113.
33. Priyamvada L, Suthar MS, Ahmed R, Wrammert J. 2017. Humoral immune responses against Zika virus infection and the importance of preexisting flavivirus immunity. J Infect Dis 216:S906-S911. https://doi.org/10.1093/ infdis/jix513.
34. Kuan G, Gordon A, Aviles W, Ortega O, Hammond SN, Elizondo D, Nuñez A, Coloma J, Balmaseda A, Harris E. 2009. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170:120-129. https://doi.org/10.1093/aje/kwp092.
35. Mattia K, Puffer BA, Williams KL, Gonzalez R, Murray M, Sluzas E, Pagano D, Ajith S, Bower M, Berdougo E, Harris E, Doranz BJ. 2011. Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One 6:e27252. https://doi.org/ 10.1371/journal.pone.0027252.
36. Waggoner JJ, Gresh L, Mohamed-Hadley A, Ballesteros G, Davila MJ, Tellez Y, Sahoo MK, Balmaseda A, Harris E, Pinsky BA. 2016. Singlereaction multiplex reverse transcription PCR for detection of Zika, chikungunya, and dengue viruses. Emerg Infect Dis 22:1295-1297. https:// doi.org/10.3201/eid2207.160326.
37. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, Stanfield SM, Duffy MR. 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14:1232-1239. https://doi.org/10.3201/eid1408.080287.
38. Waggoner JJ, Ballesteros G, Gresh L, Mohamed-Hadley A, Tellez Y, Sahoo MK, Abeynayake J, Balmaseda A, Harris E, Pinsky BA. 2016. Clinical evaluation of a single-reaction real-time RT-PCR for pan-dengue and Chikungunya virus detection. J Clin Virol 78:57-61. https://doi.org/10.1016/j.jcv.2016.01.007.
39. Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nuñez A, Balmaseda A, Harris E. 2011. Evaluation of the traditional and revised WHO classifications of dengue disease severity. PLoS Negl Trop Dis 5:e1397. https:// doi.org/10.1371/journal.pntd.0001397.
40. Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, Vaughn DW, Putnak R, Gibbons RV, Jarman R, Endy TP. 2009. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance. Am J Trop Med Hyg 81:825-833. https://doi.org/10.4269/ajtmh.2009.08-0625.
41. Balmaseda A, Gordon A, Gresh L, Ojeda S, Saborio S, Tellez Y, Sanchez N, Kuan G, Harris E. 2016. Clinical attack rate of chikungunya in a cohort of Nicaraguan children. Am J Trop Med Hyg 94:397-399. https://doi.org/10.4269/ajtmh.15-0413.
42. Classen DC, Morningstar JM, Shanley JD. 1987. Detection of antibody to murine cytomegalovirus by enzyme-linked immunosorbent and indirect immunofluorescence assays. J Clin Microbiol 25:600-604.